Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,421,522 papers from all fields of science
Search
Sign In
Create Free Account
Dapsone 0.05 MG/MG Topical Gel
Known as:
DAPSONE 5% GEL,TOP
, 5% Dapsone Gel
, DAPSONE 5% GEL,TOP [VA Product]
Expand
The 5% gel preparation of dapsone, a synthetic derivative of diamino-sulfone with anti-inflammatory and anti-bacterial properties. As a structural…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
AIDS-Related Opportunistic Infections
Dapsone
Dermatitis Herpetiformis
Drug Allergy
Expand
Broader (1)
ANTIACNE AGENTS,TOPICAL
Narrower (1)
Dapsone 0.05 MG/MG Topical Gel [Aczone]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype.
Susan C. Taylor
,
F. Cook-Bolden
,
+5 authors
N. Alvandi
Journal of Drugs in Dermatology
2018
Corpus ID: 3437189
BACKGROUND Acne vulgaris (acne) is prevalent in individuals with skin of color, often with more frequent sequelae than in…
Expand
2016
2016
Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled…
L. Eichenfield
,
Ted Lain
,
+5 authors
A. Kaoukhov
Journal of Drugs in Dermatology
2016
Corpus ID: 25370600
BACKGROUND Dapsone gel, 5% is administered twice daily for the treatment of acne vulgaris, and some patients may find adherence…
Expand
2016
2016
The Efficacy and Safety of Topical Dapsone Gel, 5% for the Treatment of Acne Vulgaris in Adult Females With Skin of Color.
A. Alexis
,
C. Burgess
,
+5 authors
Conor J. Gallagher
Journal of Drugs in Dermatology
2016
Corpus ID: 2123663
BACKGROUND Topical dapsone gel, 5% is approved for treatment of acne vulgaris but has not been studied specifically in women with…
Expand
2015
2015
Heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages.
T. Warkentin
,
E. Safyan
,
L. Linkins
New England Journal of Medicine
2015
Corpus ID: 75924043
Two cases are described in which adrenal hemorrhage was misdiagnosed as the result of too much anticoagulation when the cause was…
Expand
2010
2010
Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.
A. Fleischer
,
A. Shalita
,
L. Eichenfield
,
W. Abramovits
,
A. Lucky
,
S. Garrett
Journal of Drugs in Dermatology
2010
Corpus ID: 36768864
PURPOSE To evaluate the safety and efficacy of dapsone gel 5% in the treatment of acne when used in combination with adapalene…
Expand
Highly Cited
2009
Highly Cited
2009
Randomized Trial of Artesunate+Amodiaquine, Sulfadoxine-Pyrimethamine+Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania
T. Mutabingwa
,
K. Muze
,
+4 authors
C. Whitty
PLoS ONE
2009
Corpus ID: 17439968
Background Malaria in pregnancy is serious, and drug resistance in Africa is spreading. Drugs have greater risks in pregnancy and…
Expand
Highly Cited
2008
Highly Cited
2008
Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
W. Piette
,
Susan C. Taylor
,
D. Pariser
,
M. Jarratt
,
P. Sheth
,
D. Wilson
Archives of Dermatology
2008
Corpus ID: 13018652
OBJECTIVE To evaluate the risk of hemolysis in subjects with glucose-6-phosphate dehydrogenase (G6PD) deficiency who were treated…
Expand
2008
2008
Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents.
S. Raimer
,
J. Maloney
,
+4 authors
S. Garrett
Cutis (New York, N.Y.)
2008
Corpus ID: 21243355
Two 12-week, randomized, vehicle-controlled. double-blinded pivotal studies and a 12-month. long-term, open-label, noncomparative…
Expand
Highly Cited
2007
Highly Cited
2007
Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment.
A. Lucky
,
J. Maloney
,
+4 authors
S. Garrett
Journal of Drugs in Dermatology
2007
Corpus ID: 12846383
Dapsone gel 5%, a topical formulation of dapsone, was shown to deliver clinically effective doses of dapsone with minimal…
Expand
2007
2007
Pharmacokinetics of Dapsone Gel, 5% for the Treatment of Acne Vulgaris
D. Thiboutot
,
J. Willmer
,
H. Sharata
,
R. Halder
,
S. Garrett
Clinical Pharmacokinetics
2007
Corpus ID: 26008578
BackgroundOral dapsone has been available for over 60 years and has been used to treat severe acne vulgaris; however, the oral…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE